期刊文献+

新疆地区癫痫患儿拉考沙胺稳态血药浓度的影响因素及参考范围初探

Factors Affecting Steady-State Plasma Concentration of Lacosamide in Children with Epilepsy in Xinjiang and Preliminary Establishment of Reference Range
下载PDF
导出
摘要 目的:探讨新疆地区癫痫患儿拉考沙胺(LCM)稳态血药浓度的影响因素,初步建立LCM稳态血药浓度的参考范围,为临床个体化用药提供参考。方法:收集新疆地区规律服用LCM并达到稳态血药浓度的4~14岁癫痫患儿313例,测定血药浓度,分析年龄、性别、民族、剂量、合并用药等因素对血药浓度的影响,并初步建立稳态血药浓度的参考范围。结果:新疆地区癫痫患儿的LCM浓度剂量比(CDR)无性别和民族差异(P>0.05);4~6岁组给药剂量高于7~14岁组,而CDR低于7~14岁组(P均<0.01);LCM单药组给药剂量和血药浓度低于LCM+其他抗癫痫药物组(P均<0.05)。总体LCM稳态血药浓度参考范围为2.02~14.47μg/mL。结论:临床使用LCM控制和治疗儿童癫痫的过程中,有必要进行治疗药物监测,以便及时调整剂量,更好地控制癫痫发作。 Objective:To explore the factors affecting the steady-state plasma concentration of lacosamide(LCM)in children with epilepsy in Xinjiang,and to establish the reference range of steady-state plasma concentration of LCM,so as to provide theoretical basis for clinical individualized drug use.Methods:The serum drug concentration was collected and measured in 313 children with epilepsy in Xinjiang who regularly took LCM and reached steady-state blood concentration,and the effects of age,gender,ethnicity,dosage and combined use on the serum concentration of LCM were analyzed,and the reference range of steady-state serum concentration of LCM was preliminarily established.Results:There was no significant difference in LCM concentration-dose ratio(CDR)values among children with epilepsy of different genders and ethnic groups(P>0.05).The dosage of the 4 to 6 age group was significantly higher than that of the 7 to 14 age group,and the CDR results of the 7 to 14 age group were significantly higher than that of the 4 to 6 age group(all P<0.01).The concentration results of the children in the LCM single drug group were significantly lower than those of the LCM combined with other antiepileptic drugs groups(all P<0.05).The reference range of steady-state blood concentration of LCM in this study was 2.02-14.47μg/mL.Conclusion:During the clinical use of LCM to control and treat epilepsy in children,it is necessary to monitor the therapeutic drug of LCM in order to adjust its dosage in time and better control epileptic seizures.
作者 于静 何磊 帕拉提·热合曼 冯继荣 孙岩 Yu Jing;He Lei;Palati·Reheman;Feng Jirong;Sun Yan(Children’s Hospital of Xinjiang Uygur Autonomous Region,Xinjiang Hospital of Beijing Children’s Hospital,Urumqi 830000,China)
出处 《儿科药学杂志》 CAS 2023年第4期7-10,共4页 Journal of Pediatric Pharmacy
基金 中国抗癫痫协会-CAAE癫痫科研基金-UCB基金,编号CU-2022-032。
关键词 癫痫 儿童 拉考沙胺 血药浓度 参考范围 epilepsy children lacosamide plasma concentration reference range
  • 相关文献

参考文献2

二级参考文献23

  • 1LaRoche SM, Helmers SL. The new antiepileptic drugs: scientific review[J]. J Am Med Assoc, 2004, 291 (5) : 605-614.
  • 2LaRoche SM, Helmers SL. The new antiepileptic drugs clinical applications[J]. J Am Med Assoc, 2004, 291 (5) 615-620.
  • 3Hitiris N, Brodie MJ. Modem antiepileptic drugs: guidelines and beyond[J]. Curr Opin Neurol, 2006, 19 (2) : 175-180.
  • 4French JA, Kanner AM, Bautista J, et al. Efficacy and tolerability of the new antiepileptic drugs I: treatment of new onset epilepsy: report of the Therapeutics and Technology Assessment Subcommittee and Quality Standards Subcommittee of the American Academy of Neurology and the American Epilepsy Society [J]. Neurology, 2004, 62 (8): 1252-1260.
  • 5National Institute for Health and Clinical Excellence. Technology appraisal guidance 76: newer drugs for epilepsy in adults [EB/OL]. (2005-07-05) [2011-07-05]. http://www. nice.org.uk/TA076guidance.
  • 6National Collaborating Centre for Primary Care. The diagnosis and management of the epilepsies in adults and children in primary and secondary care EEB/OL]. (2005- 07-05) [2011-07-05]. http://www.rcgp.org.uk/nccpc/docs/ guidelines_epilepsies.pdf, and at http://www.nice.org.uk/pdf/ CG020NICEguideline.pdf.
  • 7Frost S, Crawford P, Mera S, et al. National statement of good practice for the treatment and care of people who have epilepsy. Joint Epilepsy Council 2002 [EB/OL]. (2005-07- 05) [2011-07-05]. http://www.jointepilepsycouncil.org.uk/ nsgoodprac.asp.
  • 8Scottish Intercollegiate Guidelines Network. Diagnosis and management of epilepsy in adults. A national clinical guideline 2003: Addendum released June 2004[EB/OL]. (2005-07-05) E2011-07-05] .http://www.sign.ac.uk/pdf/ sign70.pdf, http://www.sign.ac.uk/guidelines/fulltext/70/.
  • 9Ross SD, Estok R, Chopra S, et al. Management of newly diagnosed patients with epilepsy: a systematic review of the literature. Evidence Report/Technology Assessment No.39 (Contract 290-97-0016 to MetaWorks, Inc.) AHRQ Publication No. 01-E038. Rockville, MD: Agency for Healthcare Research and Quality[EB/OL]. (2005-07- 05) [2011-07-05]. http://www.ncbi.nlm.nih.gov/books/ bv.fcgi?rid=hstat 1 .chapter.55359.
  • 10Glauser T, Ben-Menachem E, Bourgeois B, et al. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes [J]. Epilepsia, 2006, 47 (7) : 1094-1120.

共引文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部